Skip to main content

Central banks

Deutsche Bank reveals role in 9/11 liquidity facility

Michael Reuther, global head of funding at Deutsche Bank, has revealed today how the European Central Bank and the Federal Reserve Bank of New York created an emergency €50 billion ‘synthetic’ liquidity facility in the wake of last year’s World Trade…

BIS seeks replacement for Crockett

BASEL - The Bank for International Settlements (BIS), the so-called central bankers' central bank, said in September it had set up a committee to help find a replacement for BIS general manager Andrew Crockett who leaves the bank at the end of March next…

Factoring in stock options

In the wake of recent corporate scandals, support has spread rapidly for including the cost of employee stock options as an expense item in corporate income statements. David Rowe argues that while some reform is appropriate, present trends could end up…

Learning the lessons

Risk’s quarterly round-up of corporate risk revelations shows that increasing shareholder and regulator expectations in the wake of US accounting scandals are having some effect on corporate disclosure, but companies still complain about losses from…

Pricing debate bedevils employee option accounting

US corporates are lining up to advertise their virtue by being the latest to account for their employee stock options as an expense. But with no consensus on how to price these instruments, will it bring more clarity or confusion?

Correlation and credit risk

Active development of full credit portfolio modelling continues apace, even though it is not recognised in the proposed Basel II framework.

Greenspan defends Fed’s role in tech bubble

The US Federal Reserve’s chairman, Alan Greenspan, claimed that it is far from obvious that a bubble, even if identified early, can be pre-empted by a central bank without inducing a substantial contraction in the economy, but conceded that better models…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here